H-1B sponsorship profile: Chinook Therapeutics Inc. Across U.S. Department of Labor LCA disclosures, Chinook Therapeutics Inc filed 2 Labor Condition Applications covering 2 H-1B worker positions between fiscal year 2023 and fiscal year 2024. The employer’s DOL certification rate sits at 100% (2 certified of 2 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Chinook Therapeutics Inc’s H-1B petitions range from $151,237 at the low end to $179,878 at the high end, with a petition-weighted average of $165,558. That range reflects the mix of occupations the company sponsors, led by Sr. Manager, CMC (1 petitions at $151,237 avg), followed by Associate Director, Statistical Programming. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Chinook Therapeutics Inc is headquartered in Seattle, WA under NAICS code 541714, and places H-1B workers across 2 states, most heavily in CA, WA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Chinook Therapeutics Inc ranks. By H-1B petition volume, Chinook Therapeutics Inc is #48,558 of 119,880 employers nationally and #925 of 2,468 employers headquartered in WA. Both ranks are computed live from the same underlying petition counts, not a separate estimate.